drugset / Trial / NCT00630357

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

NCT00630357

Phase 4 Completed 14 enrolled UCB Pharma
Non-randomizedSingle-groupOpen-labelTreatment

Summary

A cohort of patients who became seizure-free during add-on treatment to one standard AED with Keppra in a previous trial (N01031) were followed to assess whether seizure freedom was maintained. Tolerability was documented.

Timeline

Start
2003-03
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified

Indications